Life Sciences Tools and Services
Company Overview of BioNano Genomics, Inc.
BioNano Genomics, Inc. offers a platform to analyze the long segments of genomic DNA and other long biomolecules structural variations. The company offers nanoAnalyzer System that allows users to visualize the whole genome capturing long molecules at high resolution; and Irys System, a genome mapping system that empowers genomics researchers to discover structural variation analysis and sequence assemblies. Its platform provides researchers and clinicians with a picture of genomes with insights into how the individual components of genomes are ordered, arranged, and interact with each other. The company works with institutions in life science, translational research, molecular diagnostics, a...
3545 John Hopkins Court
San Diego, CA 92121
Founded in 2003
Key Executives for BioNano Genomics, Inc.
Founder and Chief Scientific Officer
Vice President of Corporate Development
Vice President of Global Commercial Operations
Compensation as of Fiscal Year 2014.
BioNano Genomics, Inc. Key Developments
BioNano Genomics, Inc. Appoints Mike Ward to the Senior Executive Management Team and Vice President, Corporate Development
May 20 14
BioNano Genomics, Inc. announced the appointment of Mr. Mike Ward as a member of the senior executive management team and vice president, corporate development. Mr. Ward has more than 20 years of life sciences-dedicated investment banking, venture capital and private equity experience.
Before joining BioNano Genomics, Mr. Ward was at Lurie Investment Fund where he was responsible for managing the life sciences venture capital and private equity investments of the Lurie family. Mr. Ward guided senior executive management teams of Lurie's life sciences portfolio companies in conducting business and corporate development, clinical and regulatory strategy, commercialization planning, intellectual property management, M&A and financings. During his tenure, he also served on the boards of a number of life sciences portfolio companies on behalf of Lurie.
BioNano Genomics Appoints Joel Jung as Chief Financial Officer
Mar 11 14
BioNano Genomics announced the appointment of Mr. Joel Jung as Chief Financial Officer. Mr. Jung has more than 17 years of experience in corporate finance and executive leadership of private and public biotech companies. Before joining BioNano Genomics, Mr. Jung was CFO of Agraquest, Inc.
BioNano Genomics, Inc. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-16-2014 12:00 PM
Jan 9 14
BioNano Genomics, Inc. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-16-2014 12:00 PM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States. Speakers: R. Erik Holmlin, Chief Executive Officer, President and Director.
Similar Private Companies By Industry
Recent Private Companies Transactions
June 12, 2014
September 17, 2013